Changes to the Injeq Plc. Board according to the decisions at the Annual General Meeting

On April 17, 2023 the Annual General Meeting made the regular decision as defined in the by-laws.


In the Annual General Meeting the new Board of Directors was elected and the five members are

Jari Hyttinen

Tommi Majaus

Tomi Numminen

Tommi Rasila

Piritta Setälä


On April 17, 2023 the new Board had the first meeting and Tomi Numminen was elected as the chairman of the Board of Directors and Tommi Rasila was elected as the vice-chair.

Injeq’s distributor network is expanding outside Europe

Injeq Plc is proud to introduce Mareen Group, the new distributor of Injeq in the Kuwaiti market. Mareen group, founded […]
Read more »

Injeq introduced to health tech in Hong Kong

Injeq visited Hong Kong as part of the Finnish HealthTech delegation. There were many interesting introductions of business opportunities in […]
Read more »

Injeq enters the Czech and Slovakian market

Injeq  and S. A. B. Impex, s.r.o.  have signed a distribution agreement covering the Czech Republic and Slovakia. S.A.B. Medical […]
Read more »

Injeq participates the Congress of EPNS

          The 15th EPNS Congress will take place at the Prague Conference Centre, Prague, Czech Republic […]
Read more »

Injeq participating GNPI 2023, neonatology and pediatric intensive care congress in Hamburg in June

Germany’s 49th Annual Meeting of the Society for Neonatology and Pediatric Intensive Care Medicine will be held in Hamburg from […]
Read more »

Vingmed and Injeq signed the distribution agreement for the Norwegian market

Vingmed AS is part of the Vingmed Group, one of the largest healthcare providers in the Nordic countries in areas […]
Read more »